Cita APA

Hallström, T., Uhde, M., Singh, B., Skerka, C., Riesbeck, K., & Zipfel, P. F. (2015). Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack. PLoS One.

Chicago Style Citation

Hallström, Teresia, Melanie Uhde, Birendra Singh, Christine Skerka, Kristian Riesbeck, i Peter F. Zipfel. "Pseudomonas Aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack." PLoS One 2015.

Cita MLA

Hallström, Teresia, et al. "Pseudomonas Aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack." PLoS One 2015.